KDIGO Work Group summarizes new guidelines for treating patients with diabetes and chronic kidney disease.
![New Guidelines for Treating Patients With Diabetes and Chronic Kidney Disease New Guidelines for Treating Patients With Diabetes and Chronic Kidney Disease](https://images.medindia.net/health-images/1200_1000/fda-to-reduce-risk-of-advanced-renal-cell-cancer.jpg)
‘The synopsis focuses on the key recommendations pertinent to the following issues: comprehensive care, glycemic monitoring and targets, lifestyle interventions, anti-hyperglycemic therapies, and educational and integrated care approaches to management.’
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
The evidence synthesis and meta-analysis methods undertaken for the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease were followed for the 2022 guideline update.
![twitter](https://images.medindia.net/icons/news/social/twitter.png)
![facebook](https://images.medindia.net/icons/news/social/facebook.png)
![whatsapp](https://images.medindia.net/icons/news/social/whatsapp.png)
![linkedin](https://images.medindia.net/icons/news/social/linkedin.png)
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
Clinical Guidelines for People with Diabetes and Kidney Disease
Authors from the KDIGO Work Group summarized the guideline update for ease of reference in clinical practice. The update recommends:- a layered approach to care, starting with a foundation of lifestyle interventions and first-line pharmacotherapy demonstrated to improve clinical outcomes;
- the serial introduction of medications that improve intrarenal hemodynamics (such as RAS inhibitors, SGLT2 inhibitors, MRAs, diuretics, and other antihypertensive medications);
- that health care providers should focus on preserving kidney function and maintaining well-being rather than replacing kidney function; and
- that policymakers and institutional decision makers implement team-based, integrated care focused on risk evaluation and patient empowerment to provide comprehensive care for patients with diabetes and CKD.